Creating specialized nanoparticles for medical imaging and treatment
A Fullerene-based Molecular Route towards Designer Nanoparticles
This study is working on creating tiny particles from fullerene molecules that can be used in medicine, especially to help doctors see and treat cancer more effectively.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers, the State Univ of N.j. NIH-funded |
| Lab location | 1 site (Piscataway, United States) |
| Project ID | NIH-11088827 on NIH RePORTER |
What this research studies
This research focuses on developing precise nanoparticles using fullerene molecules, which can be tailored for specific biomedical applications. By utilizing a unique structure of fullerene C60, the researchers aim to create nanoparticles that maintain their size and shape while incorporating biological functions. This approach seeks to improve the effectiveness of diagnostic tools and therapeutic agents, particularly in targeting cancer cells through advanced imaging techniques. The project involves multiple research themes that explore different applications of these molecular nanoparticles in medical imaging.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancer who may benefit from improved imaging and targeted therapies.
Not a fit: Patients with conditions unrelated to cancer or those who do not require advanced imaging techniques may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective diagnostic and therapeutic tools for cancer treatment.
How similar studies have performed: Other research has shown promise in using nanoparticles for medical applications, indicating that this approach could lead to significant advancements.
Where this research is happening
Piscataway, United States
- Rutgers, the State Univ of N.j. — Piscataway, United States (Active)
Researchers
- Principal investigator: Zhang, Jianyuan — Rutgers, the State Univ of N.j.
- Study coordinator: Zhang, Jianyuan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.